Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Publishing timestamp: 2023-12-20 07:00:01
Summary
Drugmakers are ending the year with historic firsts that will shape the pharmaceutical industry in the future. COVID vaccines and treatments saw a decline in demand, while attention shifted to weight loss medications and new Alzheimer's drugs. The weight loss drug market has become a gold rush, with Novo Nordisk and Eli Lilly leading the way. The approval of the first-ever Alzheimer's treatment and the rollout of vaccines against respiratory syncytial virus were significant milestones. However, the COVID product market saw a steep drop in demand as the world emerged from the pandemic. The pharmaceutical industry also faced challenges with the new Medicare drug price negotiations.
Sentiment: MIXED
Tickers: 4523.T-JP, JNJ, PFE, BMY, MRK, AZN-GB, LLY, AMGN, NOVO.B-DK, BIIB,
Keywords: biogen inc, pfizer inc, united states, biotech and pharmaceuticals, novo nordisk a/s, amgen inc, business news, business, eisai co ltd, pharmaceuticals, health care industry, eli lilly and co, biotechnology,